we don't know if management have been trying to do this.
its clear we have a buyer problem, so who are we going to convince to buy a ~4 mil block trade? Much easier said than done.
currently race has the worst of both worlds; a buyer problem and a seller problem. This will continue until a catalyst changes this equilibrium.
Wrt the buyer issue, possibly the preclinical synergy with PD1 may do it, or a collaboration. This may be short term. I'd say a real catalyst would be clinical results or partnership.
Wrt the seller issue, well when >50% of the sell supply dries up, this may change the dynamic. How much when there is still the buyer problem is hard to say.
Holders can decide if they want to risk opportunity cost and holding, or sell now to get a short term return in another stock and hope to buy back in before significant news drops. Keeping in mind we may get initial human trial results by end of year(if there are no delays)
IMO, blah blah...
General Comments / Chat, page-5496
-
- There are more pages in this discussion • 5,620 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |